483 Boehringer Ingelheim Pharmaceuticals Sep 2010

483 Boehringer Ingelheim Pharmaceuticals Sep 2010

$119 - Not in Stock

FDA investigators audited the Boehringer Ingelheim Pharmaceuticals - Danbury, CT, United States facility and issued inspectional observations (via FDA 483) on 01 Sep 2010.

Product details

  • Category: Human Drugs
  • Inspection end: 01 Sep 2010
  • Location: Danbury, United States
  • FEI: 1219205
Order